Deutsches Referenzzentrum für Ethik in den Biowissenschaften (DRZE)

Titel: 14th International Symposium on Recent Advances in Stem Cell Transplantation

Termin: 26.4.2007, 8:00 Uhr, bis 28.4.2007, 13:15 Uhr

Veranstaltungsort:
German Cancer Research Center (DKFZ)
Conference Center
Im Neuenheimer Feld 280
Heidelberg
Germany

Referenten: Michael Andreeff (Houston, TX, USA) *** Edward D. Ball (San Diego, CA, USA) *** Norbert Blank (Heidelberg, Germany) *** Claus Bartram (Heidelberg, Germany) *** Claudio Bordignon (Milan, Italy) *** Richard Champlin (Houston, TX, USA) *** Peter Dreger (Heidelberg, Germany) *** Gerhard Ehninger (Dresden, Germany) *** Stefan Frühauf (Osnabrück, Germany) *** Sergio A. Giralt (Houston, TX, USA) *** Rüdiger Hehlmann (Mannheim, Germany) *** Alex Heyll (Duesseldorf, Germany) *** Anthony D. Ho (Heidelberg, Germany) *** Thomas Holstein (Heidelberg, Germany) *** Richard Jones (Baltimore, MD, USA) *** Armand Keating (Toronto, ON, Canada) *** Hans-Jochem Kolb (Munich, Germany) *** Jacob M. van Laar (Leiden, Netherlands) *** Tsvee Lapidot (Rehovot, Israel) *** Ihor Lemischka (Princeton, NJ, USA) *** Liheng Li (Kansas City, MO, USA) *** Thomas Luft (Heidelberg, Germany) *** Andreas Mackensen (Regensburg, Germany) *** Jeff Miller (Minneapolis, MINN, USA) *** Albrecht Müller (Würzburg, Germany) *** Karim Nayernia (Newcastle upon Tyne, UK) *** Christof Niehrs (Heidelberg, Germany) *** Olle Ringdén (Stockholm, Sweden) *** Timm Schröder (Neuherberg, Germany) *** Radek Skoda (Basal, Switzerland) *** Miodrag Stojkovic (Valencia, Spain) *** Otmar Wiestler (Heidelberg, Germany) *** Eckart Würzner (Heidelberg, Germany) *** Axel Zander (Hamburg, Germany) *** Esmail Zanjani (Reno, NEV, USA)

Weitere Informationen:
http://cme.ucsd.edu/stemcell2007/

Kurzbeschreibung: Course Description: As we initiate this symposium at the University of California, San Diego, in March 1992, the clinical use of progenitor cells derived from peripheral blood instead of the marrow was seen with skepticism and regarded as experimental. In the meantime, the role of blood derived progenitor cells is well established. We have witnessed how stem cell research has evolved and how hematopoietic cell transplantation has become standard therapy for many types of malignancies and hereditary diseases. Above all, stem cells from the bone marrow have learned new tricks! Other than giving rise to blood and immunocompetent cells, they might possess far wider differentiation potentials than previously thought. Hematopoietic stem cells, mesenchymal stem cells, or multipotent adult progenitor cells, all derived from the bone marrow, might one day represent a valuable alternative source our pluripotent stem cells for regenerative medicine.

The topics and speakers in the present program have been selected based on proposals from participants previous meetings. More opportunities will be offered for abstract presentations and the the best abstracts will be integrated into the main sessions.

Objectives: The attendee will be familiar with the indications and current results of hematopoietic stem cell transplantation. In addition, the attendee will be familiar with the most recent advances in supportive care, donor stem cell sources, and the role of hematopoietic stem cells in tissue repair.

Target Audience: This course is designed for researchers and clinicians in Hematology/Oncology who work in the field of Stemcell Transplantation.

Kontakt: Frau C. Veronica Lopez
Frau C. Veronica Lopez
Universitätsklinikum Heidelberg
Abteilung für Innere Medizin V
Im Neuenheimer Feld 410
69120 Heidelberg
Tel.: +49 - (0)6221 - 56 87 18
Fax: +49 - (0)6221 - 56 58 13
Claudia.Lopez@med.uni-heidelberg.de
http://www.klinikum.uni-heidelberg.de/Innere-Medizin-V-Startseite.749.0.html

Veranstalter: University of California, San Diego - School of Medicine, Medizinische Klinik V - Abteilung Hämatologie, Onkologie und Rheumatologie - Deutsches Krebsforschungszentrum, Heidelberg

Wissenschaftliche Leitung: Anthony D. Ho, MD, PhD (University of Heidelberg, Germany), Edward D. Ball, MD (University of California, San Diego)

Schlagworte: Embryonale Stammzellen, Embryonenforschung, Organ-/Gewebetransplantation

Artikelaktionen